KevinHMerkleyMD
Ophthalmology • League City, TXCataract Related, Cornea & External Disease, Refractive Surgery
Assistant Professor, Ophthalmology & Visual Sciences, University of Texas Medical Branch SOM
Dr. Merkley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2660 Gulf Fwy S
League City, TX 77573Phone+1 832-505-2400Fax+1 281-337-0843
Education & Training
University of California (Irvine)Fellowship, Cornea, External Diseases, and Refractive Surgery, 1991 - 1992
St Luke's Medical CenterResidency, Ophthalmology, 1988 - 1991
Geisinger Health System (Danville)Internship, Internal Medicine, 1987 - 1988
University of Utah School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1993 - Present
UT State Medical License 1992 - 2026
TX State Medical License 2010 - 2024
GA State Medical License 2010 - 2015
WA State Medical License 2010 - 2013
ID State Medical License 2005 - 2009
OH State Medical License 1988 - 1992- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Measuring Relative Afferent Pupillary Defect Start of enrollment: 2023 May 04
Roles: Principal Investigator
Publications & Presentations
PubMed
- 3 citationsCXCR3 deletion aggravates corneal neovascularization in a corneal alkali-burn model.Shengguo Li, Shuizhen Shi, Fan Xia, Ban Luo, Yonju Ha
Experimental Eye Research. 2022-12-01 - 14 citationsFormulation Stabilization and Disaggregation of Bevacizumab, Ranibizumab and Aflibercept in Dilute SolutionsSteven A. Giannos, Edward R. Kraft, Zhen-Yang Zhao, Kevin H. Merkley, Jiyang Cai
Pharmaceutical Research. 2018-02-28 - 8 citationsPhotokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera.Steven A. Giannos, Edward R. Kraft, Zhen-Yang Zhao, Kevin H. Merkley, Jiyang Cai
Pharmaceutical Research. 2018-03-29
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
